Home » Authors » Nuala Moran

Articles by Nuala Moran

Avidex Completes £10M Funding For Programs In T-Cell Receptors

Jan. 17, 2001

Cambridge Drug Eyes Licensing Deals Following £7.5M Financing

Jan. 17, 2001

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Jan. 10, 2001

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Jan. 10, 2001

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Jan. 10, 2001

Phytopharm Sees Encouraging Results In Phase I P54 Study

Jan. 10, 2001

Oxxon Plans Moves Into Phase II Following £4.7M Private Funding

Jan. 3, 2001

Scotia Sells Assets, Buys Time While Awaiting Foscan Decision

Jan. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...